Inogen Inc (INGN) — 13F Holders Deep Dive (Q2 2026)

INGN ranks #4020 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

129 institutions disclose a position in INGN, but none treat it as a major bet — even Peapod Lane Capital LLC, its most concentrated holder, allocates just 1.1% of its own portfolio to it.

Cliff Asness has added to its INGN position for two straight quarters, increasing it by $4.5M to reach $6.0M today.

Nuveen, LLC has trimmed its INGN position for two straight quarters, cutting it by $1.6M while still holding $1.2M.

INGN is down 0.7% today, but institutions show net buying of $9.3M this quarter — a divergence between today's price move and the underlying institutional flow.

INGN reported a net loss of $24.6M over the trailing twelve months.

• Not yet profitable — net loss of $24.6M over the trailing twelve months
• Revenue grew 5.1% year over year
• Net income improved year over year, from -$26.0M to -$24.6M
• Operating cash flow was negative, using $11.2M in cash
• Current ratio of 3.12x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.55x equity — within a conventional range